☆ 4.7 Editorial Material

Uncovering the mechanism of action of aspirin in HCC chemoprevention

EBIOMEDICINE (2019)

Get Full Text
Add to Collection

Journal

EBIOMEDICINE
Volume 46, Issue -, Pages 21-22

Publisher

ELSEVIER
DOI: 10.1016/j.ebiom.2019.07.047

Keywords

Aspirin; Hepatocellular carcinoma; Chemoprevention

Categories

Medicine, General & Internal Medicine, Research & Experimental

Funding

  1. US National Institutes of Health (NIH) [U19-AI123862]
  2. National Institute of Allergy & Infectious Diseases (NIAID)
  3. National Cancer Institute (NCI) [R03AI131066, 1R21CA209940-01A1]
  4. ARC Foundation for Cancer Research (TheraHCC) [TheraHCC2.0 IHUARC IHU201301187, IHUARC2019 IHU201901299]
  5. European Union [H2020-2015-667273-HEP-CAR]
  6. French National Research Agency as part of the Investments for the Future Program

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.